欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2075/001
药品名称
Fosaprepitant Hikma
活性成分
FOSAPREPITANT 150.0 mg
剂型
Powder for solution for infusion
上市许可持有人
Hikma Farmacêutica
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Austria (AT)
Italy (IT)
Spain (ES)
Germany (DE)
Fosaprepitant CTTQ 150 mg Pulver zur Herstellung einer Infusionslösung
许可日期
2019/05/14
最近更新日期
2024/02/26
药物ATC编码
A04AD12 aprepitant
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR
|
PAR_2075_Final
Date of last change:2019/07/01
Final Product Information
|
common-outer-clean
Date of last change:2019/07/01
Final Product Information
|
common-pl-clean
Date of last change:2019/07/01
Final Product Information
|
common-spc-clean
Date of last change:2019/07/01
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase